Green Cross LabCell Corp (144510):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Green Cross LabCell Corp (144510) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9393
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Green Cross LabCell Corp (GCLabCell), a subsidiary of GC Pharma, is a biotechnology company that offers biopharmaceuticals. The company’s products include specialty medicines, blood products and vaccines, generic drugs, parenteral products, and genetically-modified hemophilia A drug Greenjun F and Hunter syndrome treatment Hunterjee. It also provides cell therapy products, biotechnology products such as medicine, blood, and specimens, among others. GCLabCell offers services such as cell banking, clinical laboratory services, physical examination services, healthcare research, specimen inspection, clinical trials, bio logistics, and professional and safe responsible transportation services, among others. The company provides its products and services through its distributors located across South Korea. GCLabCell is headquartered in Yongin, South Korea.

Green Cross LabCell Corp (144510) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Green Cross LabCell Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Feldan Therapeutics and Green Cross LabCell Enter into Research Partnership 10
OGD2 Pharma Enters into Agreement with Green Cross LabCell 11
Oxford BioMedica Enters into Agreement with Green Cross 12
Equity Offering 13
Green Cross LabCell Prices IPO of Shares for USD32 Million 13
Green Cross LabCell Corp – Key Competitors 14
Green Cross LabCell Corp – Key Employees 15
Green Cross LabCell Corp – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Green Cross LabCell Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Green Cross LabCell Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Feldan Therapeutics and Green Cross LabCell Enter into Research Partnership 10
OGD2 Pharma Enters into Agreement with Green Cross LabCell 11
Oxford BioMedica Enters into Agreement with Green Cross 12
Green Cross LabCell Prices IPO of Shares for USD32 Million 13
Green Cross LabCell Corp, Key Competitors 14
Green Cross LabCell Corp, Key Employees 15

List of Figures
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Green Cross LabCell Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Green Cross LabCell Corp (144510):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RHI AG:戦略・SWOT・企業財務分析
    RHI AG - Strategy, SWOT and Corporate Finance Report Summary RHI AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Ardent Health Services:企業の戦略・SWOT・財務分析
    Ardent Health Services - Strategy, SWOT and Corporate Finance Report Summary Ardent Health Services - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nuvo Pharmaceuticals Inc (NRI):企業の財務・戦略的SWOT分析
    Summary Nuvo Pharmaceuticals Inc (Nuvo), formerly Nuvo Research Inc, is a healthcare company that offers portfolio of commercial products and pharmaceutical manufacturing capabilities. The company’s product portfolio includes pennsaid, heated lidocaine and tetracaine patches. Its products deliver dr …
  • Tennessee Valley Authority:企業の戦略・SWOT・財務情報
    Tennessee Valley Authority - Strategy, SWOT and Corporate Finance Report Summary Tennessee Valley Authority - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • TAG Oil Ltd (TAO):企業の財務・戦略的SWOT分析
    Summary TAG Oil Ltd (TAG Oil) is an oil and gas exploration company engaged in the production of crude oil and natural gas across Canada. The company owns and operates oil and gas properties in Surat Basin and Taranaki Basin. The Taranaki Basin is located to the North Island of New Zealand. The comp …
  • Frutarom Industries Ltd (FRUT):企業の財務・戦略的SWOT分析
    Frutarom Industries Ltd (FRUT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Torax Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary TORAX Medical Inc (Torax Medical), a subsidiary of Ethicon US LLC, is a healthcare company that offers technology solutions. The company offers LINX reflux management system, a clinical stage medical device. Torax Medical offers treatment for gastro esophageal reflux disease that can turn in …
  • Medical College of Wisconsin-医療機器分野:企業M&A・提携分析
    Summary Medical College of Wisconsin (MCW) is a medical educational institution that offers biomedical education, patient care and research services. The college provides medical courses in the fields of biomedical sciences, post-doctoral education, patient and public health. It offers these courses …
  • Virgin Media Inc.:企業の戦略的SWOT分析
    Virgin Media Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Attana AB-製薬・医療分野:企業M&A・提携分析
    Summary Attana AB (Attana) develops, manufactures and markets reagent kits and chip surfaces. The company offers products such as instruments, chip surfaces, reagents, kits and consumables; softwares, and accessories and spare parts. Its services comprise contract research, instrument training, atta …
  • Komax Holding AG (KOMN):企業の財務・戦略的SWOT分析
    Komax Holding AG (KOMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Infinity Turbine LLC:企業の戦略的SWOT分析
    Infinity Turbine LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Fresenius Kabi AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Fresenius Kabi AG (Fresenius Kabi), a wholly owned subsidiary of Fresenius SE & Co KGaA, develops, manufactures and markets pharmaceuticals products and medical devices. The company's product portfolio includes intravenously administered drugs, infusion therapy products, medical devices and …
  • Epuron Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary Epuron Pty Ltd (Epuron), formerly Taurus Energy Pty Ltd, a subsidiary of Epuron Holding GmbH & Co KG, is a renewable energy company that develops wind and solar energy projects. The company provides resource monitoring and assessment for wind and solar energy projects including data capture …
  • JGC Holdings Corp (1963)
    JGC Holdings Corp (1963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Osaka Gas Co., Ltd.:戦略・SWOT・企業財務分析
    Osaka Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Osaka Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • OncoSil Medical Ltd (OSL):医療機器:M&Aディール及び事業提携情報
    Summary OncoSil Medical Ltd (OncoSil), formerly Neuro Discovery Ltd, is a medical device company that develops and commercializes products for the treatment of pancreatic and liver cancer. The company’s lead product includes oncosil, a brachytherapy device that emits beta radiation and is implanted …
  • Infosys Ltd (INFY):企業の財務・戦略的SWOT分析
    Infosys Ltd (INFY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • GKE Corporation Limited (595):企業の財務・戦略的SWOT分析
    GKE Corporation Limited (595) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Northstar Aerospace Inc.:企業の戦略・SWOT・財務情報
    Northstar Aerospace Inc. - Strategy, SWOT and Corporate Finance Report Summary Northstar Aerospace Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆